Business, energy, technology, markets and global industry news from Business News Today

ABCD platform

PharmaDeviceNews ABCD platform
Representative image: An ophthalmology clinic scene showing retinal imaging and eye examination technology, reflecting Kodiak Sciences’ KSI-101 clinical data in macular edema secondary to inflammation and the growing role of biologics in inflammatory retinal disease treatment.
Pharma & Biotech

Could Kodiak’s KSI-101 become the first real biologic challenger in inflammatory eye disease?

Steroids still dominate MESI care. Kodiak’s KSI-101 may test whether local biologics can change inflammatory retina treatment.

Read More